speb/financial-data huggingface dataset:
Financial ratios for SNT.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -178750
Buffett classification: The Gruesome
Stock price: 0.001625
Shares outstanding: 31725958
Book value: -46250
Market cap (USD): 51554.681749999996
Debt to equity: -6.945945945945946
Current ratio: 0.36801242236024845
Quick ratio: 0.327639751552795
Buyback yield (%): 0
Retained earnings: -9877500
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SNT.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -471232.87671232875
Buffett classification: The Gruesome
Stock price: 0.0010958904109589042
Shares outstanding: 31725958
Book value: -153424.65753424668
Market cap (USD): 34768.17315068494
Debt to equity: -2.13392857142857
Current ratio: 0.38651994497936726
Quick ratio: 0.38239339752407153
Buyback yield (%): 0
Retained earnings: -11132876.712328767
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SNT.L — annual report dated 2025-06-30
Total revenue: 1160273.9726027397
Gross profit: 753424.6575342466
Operating income: -624657.5342465753
Net income: -886301.3698630137
Capital expenditures: 10958.90410958904
Operating cash flow: -124657.53424657535
Depreciation & amortization: 52054.79452054795
Net tangible assets: -471232.87671232875
Owner earnings: -845205.4794520548
Buffett classification: The Gruesome
Stock price: 0.0010958904109589042
Shares outstanding: 31725958
Book value: -153424.65753424668
Market cap (USD): 34768.17315068494
Debt to equity: -2.13392857142857
Current ratio: 0.38651994497936726
Quick ratio: 0.38239339752407153
Interest coverage ratio: -17.538461538461537
COGS to revenue (%): 35.064935064935064
SG&A to revenue (%): 118.77213695395514
Free cash flow (dilution-adjusted): -135616.43835616438
Buyback yield (%): 0
Retained earnings: -11132876.712328767
Inventory turnover: 98.99999999999999
Receivables turnover: 5.42948717948718
Capitalized R&D asset: 0
FCF margin (%): -11.688311688311687
Revenue growth (%): 28.9193302891933
Rule of 40 score: 17.23101860088161
Financial ratios for SRL.V — annual report dated 2021-12-31
Total revenue: 0
Gross profit: -118753.54330708661
Operating income: -1438621.2598425196
Net income: 2147733.070866142
Capital expenditures: 2748064.5669291336
Operating cash flow: -1226522.8346456692
Depreciation & amortization: 154066.92913385827
Net tangible assets: 22658404.72440945
Owner earnings: -446264.5669291336
Return on net tangible assets (%): -1.9695321553171024
Buffett classification: The Gruesome
Stock price: 0.23622047244094488
P/E ratio: 29.093880381475284
Shares outstanding: 264523597
Book value: 22658404.724409446
P/B ratio: 2.7577355870867337
Market cap (USD): 62485889.05511811
Debt to equity: 0
Current ratio: 12.841907529551682
Quick ratio: 11.289834122456291
Free cash flow (dilution-adjusted): -4195040.157480315
Buyback yield (%): 0
Retained earnings: -18743933.07086614
Inventory turnover: 0.24176597511437703
Receivables turnover: 0
Capitalized R&D asset: 115495.27559055117
ROCI (R&D-adjusted, %): -5.978881129050444
Rule of 40 score: 0
Financial ratios for SRL.V — annual report dated 2022-12-31
Total revenue: 0
Gross profit: -155670.5882352941
Operating income: -810175.7352941176
Net income: -2871166.176470588
Capital expenditures: 1832124.2647058822
Operating cash flow: 166137.5
Depreciation & amortization: 155670.5882352941
Net tangible assets: 21070063.970588233
Owner earnings: -4547619.852941176
Return on net tangible assets (%): -21.583322477279673
Buffett classification: The Gruesome
Stock price: 0.09558823529411764
Shares outstanding: 264523597
Book value: 21070063.970588233
P/B ratio: 1.2000601358485783
Market cap (USD): 25285343.83088235
Debt to equity: 0
Current ratio: 6.1772225647249455
Quick ratio: 5.246826290867658
Free cash flow (dilution-adjusted): -1885154.4117647058
Buyback yield (%): 0
Retained earnings: -20374691.911764704
Inventory turnover: 0.367240595739071
Receivables turnover: 0
Capitalized R&D asset: 165482.56993978692
ROCI (R&D-adjusted, %): -3.7198964267482157
Rosenberg metric: -0.3196411692118402
Rule of 40 score: 0
Financial ratios for SRL.V — annual report dated 2023-12-31
Total revenue: 0
Gross profit: -135662.87878787878
Operating income: -1696723.4848484849
Net income: -4299486.363636363
Capital expenditures: 901729.5454545454
Operating cash flow: -375353.78787878784
Depreciation & amortization: 135662.87878787878
Net tangible assets: 17706924.242424242
Owner earnings: -5065553.030303029
Return on net tangible assets (%): -28.607752317403644
Buffett classification: The Gruesome
Stock price: 0.03787878787878788
Shares outstanding: 264523597
Book value: 17706924.242424242
P/B ratio: 0.5658709035243018
Market cap (USD): 10019833.21969697
Debt to equity: 0
Current ratio: 3.9084978563201
Quick ratio: 2.932488780791583
Free cash flow (dilution-adjusted): -1544454.5454545454
Buyback yield (%): 0
Retained earnings: -25291593.18181818
Inventory turnover: 0.3995078518379704
Receivables turnover: 0
Capitalized R&D asset: 98878.81237981949
ROCI (R&D-adjusted, %): -9.903682695601175
Rosenberg metric: 0.2271003684659508
Rule of 40 score: 0
Financial ratios for SRL.V — quarterly report dated 2024-09-30
Total revenue: 0
Gross profit: -17731.11111111111
Operating income: -224551.1111111111
Net income: -1834186.6666666665
Capital expenditures: 320339.2592592592
Operating cash flow: -293148.8888888889
Depreciation & amortization: 17731.11111111111
Net tangible assets: 16396486.666666666
Owner earnings: -2136794.814814815
Return on net tangible assets (%): -13.032028496438963
Buffett classification: The Gruesome
Stock price: 0.059259259259259255
Shares outstanding: 264523597
Book value: 16396486.666666664
P/B ratio: 0.95602629596756
Market cap (USD): 15675472.414814813
Debt to equity: 0
Current ratio: 4.8966340169072975
Quick ratio: 3.8774344331973363
Free cash flow (dilution-adjusted): -438385.18518518517
Buyback yield (%): 0
Retained earnings: -27876003.7037037
Inventory turnover: 0.05267790925676107
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.3695074784991204
Rule of 40 score: 0
Financial ratios for SRL.V — annual report dated 2024-12-31
Total revenue: 0
Gross profit: -72108.39160839161
Operating income: -1678579.7202797204
Net income: -3242345.4545454546
Capital expenditures: 0
Operating cash flow: -939776.9230769231
Depreciation & amortization: 72108.39160839161
Net tangible assets: 15464250.34965035
Owner earnings: -3170237.062937063
Return on net tangible assets (%): -20.50042511765689
Buffett classification: The Gruesome
Stock price: 0.04895104895104896
Shares outstanding: 264523597
Book value: 15464250.34965035
P/B ratio: 0.8373317330411248
Market cap (USD): 12948707.545454547
Debt to equity: 0
Current ratio: 5.283052846836252
Quick ratio: 3.533020490121032
Free cash flow (dilution-adjusted): -1926427.2727272727
Buyback yield (%): 0
Retained earnings: -26588431.46853147
Inventory turnover: 0.21788741233473288
Receivables turnover: 0
Capitalized R&D asset: 40218.04101535719
ROCI (R&D-adjusted, %): -10.976656980672098
Rosenberg metric: 36.57014955402052
Rule of 40 score: 0
Financial ratios for SRL.V — quarterly report dated 2024-12-31
Total revenue: 0
Gross profit: -22065.734265734267
Operating income: -331433.56643356645
Net income: -271924.47552447557
Capital expenditures: 0
Operating cash flow: -205776.9230769231
Depreciation & amortization: 22065.734265734267
Net tangible assets: 15464250.34965035
Owner earnings: -249858.7412587413
Return on net tangible assets (%): -1.6157184189946245
Buffett classification: The Gruesome
Stock price: 0.04895104895104896
Shares outstanding: 264523597
Book value: 15464250.34965035
P/B ratio: 0.8373317330411248
Market cap (USD): 12948707.545454547
Debt to equity: 0
Current ratio: 5.283052846836252
Quick ratio: 3.533020490121032
Free cash flow (dilution-adjusted): -300796.5034965035
Buyback yield (%): 0
Retained earnings: -26588431.46853147
Inventory turnover: 0.06667525974698309
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.1432242684887743
Rule of 40 score: 0
Financial ratios for SRL.V — quarterly report dated 2025-06-30
Total revenue: 0
Gross profit: -14825.547445255474
Operating income: -386991.24087591236
Net income: -450725.54744525545
Capital expenditures: 32456.20437956204
Operating cash flow: -271960.5839416058
Depreciation & amortization: 14825.547445255474
Net tangible assets: 16204199.999999998
Owner earnings: -468356.20437956206
Return on net tangible assets (%): -2.890338334379742
Buffett classification: The Gruesome
Stock price: 0.10218978102189781
Shares outstanding: 264523597
Book value: 16204199.999999998
P/B ratio: 1.6681853132246423
Market cap (USD): 27031608.452554744
Debt to equity: 0
Current ratio: 5.002044871762705
Quick ratio: 3.8790740619934865
Free cash flow (dilution-adjusted): -321578.10218978097
Buyback yield (%): 0
Retained earnings: -28857673.722627737
Inventory turnover: 0.045380712247720466
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.3882156532004815
Rule of 40 score: 0
Financial ratios for SRL.V — quarterly report dated 2025-09-30
Total revenue: 0
Gross profit: -1230.9352517985612
Operating income: -331518.70503597124
Net income: -367399.28057553957
Capital expenditures: 48903.59712230216
Operating cash flow: -163164.74820143887
Depreciation & amortization: 1230.9352517985612
Net tangible assets: 15728706.474820144
Owner earnings: -415071.9424460432
Return on net tangible assets (%): -2.6389451866911355
Buffett classification: The Gruesome
Stock price: 0.11510791366906475
Shares outstanding: 264523597
Book value: 15728706.474820144
P/B ratio: 1.935871803294915
Market cap (USD): 30448759.366906475
Debt to equity: 0
Current ratio: 2.3120700372072664
Quick ratio: 1.5125200262639529
Free cash flow (dilution-adjusted): -503240.2877697842
Buyback yield (%): 0
Retained earnings: -28809854.676258996
Inventory turnover: 0.0037469095113688376
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.107730254656953
Rule of 40 score: 0
Financial ratios for THEMISMED.NS — annual report dated 2022-03-31
Total revenue: 51608598.18013979
Gross profit: 31564473.163655546
Operating income: 11361624.68679942
Net income: 9611077.409996044
Capital expenditures: 2545786.627983648
Operating cash flow: 4535685.085058684
Depreciation & amortization: 1250138.4676249507
Net tangible assets: 37781920.08439931
Owner earnings: 8315429.249637347
Return on net tangible assets (%): 22.00901709352486
Capex to operating income (%): 22.406888963173436
Buffett classification: The Great
Stock price: 1.2154819992087564
P/E ratio: 11.647605487865116
Shares outstanding: 92100120
Book value: 37912224.71317421
P/B ratio: 2.9527688979450994
Market cap (USD): 111946037.98496637
Debt to equity: 0.2773412770741358
Current ratio: 1.9554304017765016
Quick ratio: 1.4001877306685804
Effective tax rate (%): 23.49446788855997
Interest coverage ratio: 13.179825299453869
COGS to revenue (%): 38.838731768144974
SG&A to revenue (%): 7.116734977564724
Free cash flow (dilution-adjusted): 1815481.9992087565
Buyback yield (%): 0
Retained earnings: 18573163.655545298
Inventory turnover: 2.4995247445296287
Receivables turnover: 3.8915781979022066
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 27.070535304414385
FCF margin (%): 3.5177897932275113
Rule of 40 score: 3.5177897932275113
Financial ratios for THEMISMED.NS — annual report dated 2023-03-31
Total revenue: 41955542.02192449
Gross profit: 27217807.551766142
Operating income: 6937405.602923265
Net income: 6930694.275274057
Capital expenditures: 3497429.9634591965
Operating cash flow: 1960109.6224116932
Depreciation & amortization: 1278294.7624847747
Net tangible assets: 41251144.9451888
Owner earnings: 4711559.074299635
Return on net tangible assets (%): 11.42164437025924
Capex to operating income (%): 50.41409085242845
Buffett classification: The Good
Stock price: 1.4225334957369065
P/E ratio: 18.903662527547844
Shares outstanding: 92100120
Book value: 41344872.10718636
P/B ratio: 3.1688453485049264
Market cap (USD): 131015505.66138858
Debt to equity: 0.27213887286583194
Current ratio: 1.9013350966911884
Quick ratio: 1.4057357047621444
Effective tax rate (%): 21.532264403591537
Interest coverage ratio: 7.128244599634552
COGS to revenue (%): 35.12702675240597
SG&A to revenue (%): 7.656936319693427
Free cash flow (dilution-adjusted): -1541461.6321559076
Buyback yield (%): 0
Retained earnings: 23543739.34226553
Inventory turnover: 1.7547975403179021
Receivables turnover: 2.3751585944395415
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.195279109649343
FCF margin (%): -3.674035795677229
Revenue growth (%): -18.704356441772184
Rule of 40 score: -22.37839223744941
Financial ratios for THEMISMED.NS — annual report dated 2024-03-31
Total revenue: 45165175.68053723
Gross profit: 28405360.354958627
Operating income: 4707866.650677539
Net income: 5219306.871327497
Capital expenditures: 2205660.151097254
Operating cash flow: 2649430.3873366113
Depreciation & amortization: 1468557.3809809329
Net tangible assets: 45223000.35975537
Owner earnings: 4482204.101211176
Return on net tangible assets (%): 9.91133729640804
Capex to operating income (%): 46.8505230661073
Buffett classification: The Good
Stock price: 2.6040067178502877
P/E ratio: 45.95041776760266
Shares outstanding: 92100120
Book value: 45289051.44501738
P/B ratio: 5.295525597085633
Market cap (USD): 239829331.19481763
Debt to equity: 0.25364303957947965
Current ratio: 1.9163699520659114
Quick ratio: 1.455042426865053
Effective tax rate (%): 18.561201425064368
Interest coverage ratio: 5.147020648967552
COGS to revenue (%): 37.10782715454114
SG&A to revenue (%): 8.830068788558817
Free cash flow (dilution-adjusted): 440784.2666986449
Buyback yield (%): 0
Retained earnings: 27813274.97301835
Inventory turnover: 1.9803256992984695
Receivables turnover: 2.116560407540511
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.495771530076267
FCF margin (%): 0.9759383420013786
Revenue growth (%): 7.650082692139935
Rule of 40 score: 8.626021034141313
Financial ratios for THEMISMED.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 49160582.89536551
Buffett classification: The Gruesome
Stock price: 3.2474916387959865
Shares outstanding: 92100120
Book value: 49213318.203535594
P/B ratio: 6.0775087019151535
Market cap (USD): 299094369.632107
Debt to equity: 0.19769672819290807
Current ratio: 1.9701101159740126
Quick ratio: 1.5626115741711004
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for THEMISMED.NS — quarterly report dated 2024-12-31
Total revenue: 10934409.60484905
Gross profit: 7612588.879822822
Operating income: 698065.0425457512
Net income: 60531.53048140809
Capital expenditures: 0
Depreciation & amortization: 296106.77235108986
Owner earnings: 356638.302832498
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.0571162140109567
P/E ratio: 1162.8682106874637
Shares outstanding: 92100120
Market cap (USD): 281560770.1643548
Effective tax rate (%): 68.72440375813056
Interest coverage ratio: 2.1479502169936517
COGS to revenue (%): 30.379516087938658
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for THEMISMED.NS — annual report dated 2025-03-31
Total revenue: 47406079.02735562
Gross profit: 31975800.79494973
Operating income: 4573240.589198036
Net income: 3487608.1365443063
Capital expenditures: 1606757.0727145195
Operating cash flow: 4057762.4503156417
Depreciation & amortization: 1160708.4404956745
Net tangible assets: 47026829.5534253
Owner earnings: 3041559.5043254616
Return on net tangible assets (%): 6.467711162348437
Capex to operating income (%): 35.13388463553982
Buffett classification: The Good
Stock price: 1.70696697397596
P/E ratio: 45.07727272794932
Shares outstanding: 92100120
Book value: 47065665.18587795
P/B ratio: 3.340266466400526
Market cap (USD): 157211863.1392228
Debt to equity: 0.20613154952673832
Current ratio: 1.946303145052093
Quick ratio: 1.4062569255581758
Effective tax rate (%): 24.80686781819236
Interest coverage ratio: 3.8965585935554565
COGS to revenue (%): 32.54915519062834
SG&A to revenue (%): 9.393171490038757
Free cash flow (dilution-adjusted): 2254348.8426467148
Buyback yield (%): 0
Retained earnings: 30075859.24713584
Inventory turnover: 1.5654555266294645
Receivables turnover: 2.2897013253349474
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.057385475398418
FCF margin (%): 4.755400338732604
Revenue growth (%): 4.961573409276136
Rule of 40 score: 9.71697374800874
Financial ratios for THEMISMED.NS — quarterly report dated 2025-03-31
Total revenue: 8382230.535422024
Gross profit: 5975379.939209726
Operating income: -972153.3785363572
Net income: -1129810.6149169977
Capital expenditures: 0
Depreciation & amortization: 295943.4182838438
Net tangible assets: 47026829.5534253
Owner earnings: -833867.196633154
Return on net tangible assets (%): -1.7731733237211555
Buffett classification: The Gruesome
Stock price: 1.70696697397596
Shares outstanding: 92100120
Book value: 47065665.18587795
P/B ratio: 3.340266466400526
Market cap (USD): 157211863.1392228
Debt to equity: 0.20613154952673832
Current ratio: 1.946303145052093
Quick ratio: 1.4062569255581758
Interest coverage ratio: -3.393788515691956
COGS to revenue (%): 28.71372465886396
Buyback yield (%): 0
Retained earnings: 30075859.24713584
Inventory turnover: 0.24418338482704632
Receivables turnover: 0.40485956147403984
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.925367301123945
Revenue growth (%): -23.34080358847375
Rule of 40 score: -23.34080358847375
Financial ratios for THEMISMED.NS — quarterly report dated 2025-06-30
Total revenue: 11417938.216709573
Gross profit: 5286601.919026446
Operating income: -1478410.9524923943
Net income: -1663889.538965598
Capital expenditures: 0
Depreciation & amortization: 298712.8481160777
Owner earnings: -1365176.6908495203
Buffett classification: The Gruesome
Stock price: 1.5131055464544818
Shares outstanding: 92100120
Market cap (USD): 139357202.40112334
Interest coverage ratio: -5.114768034976925
COGS to revenue (%): 53.69915462241885
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 36.2159889120099
Rule of 40 score: 36.2159889120099
Financial ratios for THEMISMED.NS — quarterly report dated 2025-09-30
Total revenue: 8793021.420518601
Gross profit: 6070868.09470124
Operating income: -638342.7282976324
Net income: -407621.19503945886
Capital expenditures: 0
Depreciation & amortization: 290248.0270574972
Net tangible assets: 42816674.1826381
Owner earnings: -117373.16798196168
Return on net tangible assets (%): -0.27412957737281657
Buffett classification: The Gruesome
Stock price: 1.5198421645997744
Shares outstanding: 92100120
Book value: 42841803.833145425
P/B ratio: 3.2673144736357354
Market cap (USD): 139977645.74069896
Debt to equity: 0.251478657750335
Current ratio: 1.7192222572960814
Quick ratio: 1.2796668788347658
Interest coverage ratio: -2.047849831820319
COGS to revenue (%): 30.95811093403219
Buyback yield (%): 0
Inventory turnover: 0.3158466857387285
Receivables turnover: 0.44972086366776254
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.3858111306423326
Revenue growth (%): -22.98941145389576
Rule of 40 score: -22.98941145389576
Financial ratios for THEMISMED.NS — quarterly report dated 2025-12-31
Total revenue: 10040458.950651666
Gross profit: 6790230.589283725
Operating income: 802606.6614681965
Net income: 1124384.5382644536
Capital expenditures: 0
Depreciation & amortization: 288849.28149715945
Owner earnings: 1413233.8197616132
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.1206416397460175
P/E ratio: 22.948383312197826
Shares outstanding: 92100120
Market cap (USD): 103211229.49760498
Effective tax rate (%): 2.832168505362059
Interest coverage ratio: 2.620285849365385
COGS to revenue (%): 32.37131267945663
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 14.186676802835452
Rule of 40 score: 14.186676802835452
Financial ratios for VISTN.OL — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.8643101482326114
Shares outstanding: 44344592
Market cap (USD): 82672072.88483468
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VISTN.OL — annual report dated 2022-12-31
Total revenue: 29116902.834008094
Gross profit: 8886538.46153846
Operating income: -617004.0485829959
Net income: -477327.935222672
Capital expenditures: 6507085.020242915
Operating cash flow: -1063765.1821862347
Depreciation & amortization: 1242914.979757085
Net tangible assets: 27680769.23076923
Owner earnings: -5741497.975708501
Return on net tangible assets (%): -20.74182956348771
Buffett classification: The Gruesome
Stock price: 1.3491902834008096
Shares outstanding: 44344592
Book value: 27680769.230769224
P/B ratio: 2.161402819010845
Market cap (USD): 59829292.64777327
Debt to equity: 0.17586640632427258
Current ratio: 1.353899279596506
Quick ratio: 0.6441614996640385
Interest coverage ratio: -2.8485981308411215
COGS to revenue (%): 69.47979490744764
SG&A to revenue (%): 6.889719301294864
Free cash flow (dilution-adjusted): -7570850.202429149
Buyback yield (%): 0
Retained earnings: 2252631.578947368
Inventory turnover: 2.3952735901061764
Receivables turnover: 4.34849973546973
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.104681673801961
FCF margin (%): -26.00156426522986
Rule of 40 score: -26.00156426522986
Financial ratios for VISTN.OL — annual report dated 2023-12-31
Total revenue: 42769253.43811395
Gross profit: 19345776.031434186
Operating income: 6738408.644400786
Net income: 4478978.388998035
Capital expenditures: 1758447.9371316307
Operating cash flow: 8899017.68172888
Depreciation & amortization: 1704027.5049115913
Net tangible assets: 31706286.836935166
Owner earnings: 4424557.956777995
Return on net tangible assets (%): 13.954828515661305
Capex to operating income (%): 26.095893406417193
Buffett classification: The Good
Stock price: 1.9312377210216112
P/E ratio: 19.12042018422669
Shares outstanding: 44344592
Book value: 31706286.83693517
P/B ratio: 2.7010399935557827
Market cap (USD): 85639948.79371317
Debt to equity: 0.0070855407875577035
Current ratio: 2.4293466526564274
Quick ratio: 1.275358772472759
Effective tax rate (%): 22.083803274206225
Interest coverage ratio: 30.27228596646072
COGS to revenue (%): 54.767094404799366
SG&A to revenue (%): 4.776855745754965
Free cash flow (dilution-adjusted): 7140569.74459725
Buyback yield (%): 0
Retained earnings: 7027504.911591356
Inventory turnover: 2.9742799765501244
Receivables turnover: 9.259107245390553
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 20.54275985781153
FCF margin (%): 16.695567891848935
Revenue growth (%): 46.88805908353728
Rule of 40 score: 63.58362697538621
Financial ratios for VISTN.OL — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.375
Shares outstanding: 44344592
Market cap (USD): 105318406
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VISTN.OL — annual report dated 2024-12-31
Total revenue: 37872109.4439541
Gross profit: 18952515.445719328
Operating income: 7528331.8623124445
Net income: 5538305.383936452
Capital expenditures: 3601323.918799647
Operating cash flow: 9519593.998234775
Depreciation & amortization: 1679523.389232127
Net tangible assets: 27319417.475728154
Owner earnings: 3616504.8543689316
Return on net tangible assets (%): 13.237854934432637
Capex to operating income (%): 47.83694428812606
Buffett classification: The Good
Stock price: 1.8994708994708993
P/E ratio: 15.208851122081162
Shares outstanding: 44344592
Book value: 27319417.475728158
P/B ratio: 3.0832012478942867
Market cap (USD): 84231262.05291004
Debt to equity: 0.004283928161820055
Current ratio: 2.238381090840876
Quick ratio: 1.0399099563851242
Effective tax rate (%): 22.005394453904763
Interest coverage ratio: 36.48246364414029
COGS to revenue (%): 49.95653602615762
SG&A to revenue (%): 3.867477994178391
Free cash flow (dilution-adjusted): 5918270.079435128
Buyback yield (%): 0
Retained earnings: 11993468.667255076
Inventory turnover: 2.7960477401682646
Receivables turnover: 9.69062083606224
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 26.573949454164797
FCF margin (%): 15.62698821462114
Revenue growth (%): -11.450150751978622
Rule of 40 score: 4.176837462642517
Financial ratios for VISTN.OL — quarterly report dated 2024-12-31
Total revenue: 10035304.501323918
Gross profit: 6560017.6522506615
Operating income: 2042894.9691085613
Net income: 1709620.476610768
Capital expenditures: 407060.90026478376
Operating cash flow: 3748014.12180053
Depreciation & amortization: 403618.71138570167
Net tangible assets: 27319417.475728154
Owner earnings: 1706178.2877316857
Return on net tangible assets (%): 6.245295271202375
Capex to operating income (%): 19.925689103948844
Buffett classification: The Great
Stock price: 1.8994708994708993
P/E ratio: 12.317245728697353
Shares outstanding: 44344592
Book value: 27319417.475728158
P/B ratio: 3.0832012478942867
Market cap (USD): 84231262.05291004
Debt to equity: 0.004283928161820055
Current ratio: 2.238381090840876
Quick ratio: 1.0399099563851242
Effective tax rate (%): 21.99895300608062
Interest coverage ratio: 13.394675925925927
COGS to revenue (%): 34.630606860158316
Free cash flow (dilution-adjusted): 3340953.221535746
Buyback yield (%): 0
Retained earnings: 11993468.667255076
Inventory turnover: 0.5135981216982978
Receivables turnover: 2.5678086677657577
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.211131050296594
FCF margin (%): 33.2919964819701
Rule of 40 score: 33.2919964819701
Financial ratios for VISTN.OL — quarterly report dated 2025-03-31
Total revenue: 10976812.977099236
Gross profit: 7092080.152671755
Operating income: 2418320.610687023
Net income: 2070324.427480916
Capital expenditures: 480248.09160305344
Operating cash flow: 520992.3664122137
Depreciation & amortization: 464790.0763358778
Net tangible assets: 31605629.770992365
Owner earnings: 2054866.4122137402
Return on net tangible assets (%): 6.501583506175522
Capex to operating income (%): 19.858743686868685
Buffett classification: The Great
Stock price: 2.1164122137404577
P/E ratio: 11.332938315896206
Shares outstanding: 44344592
Book value: 31605629.770992365
P/B ratio: 2.9694531259830867
Market cap (USD): 93851436.1221374
Debt to equity: 0
Current ratio: 2.688570839871301
Quick ratio: 1.4675796047105065
Effective tax rate (%): 22.000934680231513
Interest coverage ratio: 5.496421600520495
COGS to revenue (%): 35.39035266914124
Free cash flow (dilution-adjusted): 40744.274809160306
Buyback yield (%): 0
Retained earnings: 15036641.221374046
Inventory turnover: 0.5284801910794953
Receivables turnover: 1.7150758863344961
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.273228183759213
FCF margin (%): 0.37118492311169454
Revenue growth (%): 9.381962208033736
Rule of 40 score: 9.75314713114543
Financial ratios for VISTN.OL — quarterly report dated 2025-06-30
Total revenue: 11685203.574975174
Gross profit: 7593247.269116187
Operating income: 2467626.6137040714
Net income: 1834458.7884806355
Capital expenditures: 341012.909632572
Operating cash flow: 632174.7765640516
Depreciation & amortization: 538927.507447865
Net tangible assets: 29222343.594836146
Owner earnings: 2032373.3862959286
Return on net tangible assets (%): 6.954861028514727
Capex to operating income (%): 13.819469596362028
Buffett classification: The Great
Stock price: 2.362462760675273
P/E ratio: 18.659585767930448
Shares outstanding: 44344592
Book value: 29222343.594836146
P/B ratio: 3.5850118214286923
Market cap (USD): 104762447.23733862
Debt to equity: 0.1447926896818897
Current ratio: 1.728931876325525
Quick ratio: 0.9399602461316062
Effective tax rate (%): 21.99890216611071
Interest coverage ratio: 10.529237288135592
COGS to revenue (%): 35.01827143706977
Free cash flow (dilution-adjusted): 291161.86693147966
Buyback yield (%): 0
Retained earnings: 17483316.782522343
Inventory turnover: 0.4967091781383351
Receivables turnover: 1.3846950423045692
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.84939918881013
FCF margin (%): 2.4917141157474294
Revenue growth (%): 6.453517968775115
Rule of 40 score: 8.945232084522544
Financial ratios for VISTN.OL — annual report dated 2025-12-31
Total revenue: 45004079.601990044
Gross profit: 23079900.497512437
Operating income: 9189353.233830845
Net income: 7437910.447761194
Capital expenditures: 1659999.9999999998
Operating cash flow: 7764776.119402984
Depreciation & amortization: 2241990.0497512436
Net tangible assets: 32717810.94527363
Owner earnings: 8019900.497512437
Return on net tangible assets (%): 24.51233828243323
Capex to operating income (%): 18.06438339848191
Buffett classification: The Great
Stock price: 1.9790836653386457
P/E ratio: 11.799235590383182
Shares outstanding: 44344592
Book value: 32717810.94527363
P/B ratio: 2.682381710075402
Market cap (USD): 87761657.67330678
Debt to equity: 0.0018825232502265718
Current ratio: 2.346909594095941
Quick ratio: 1.3998039667896678
Effective tax rate (%): 22.00461190120932
Interest coverage ratio: 47.11887755102041
COGS to revenue (%): 48.71598152516853
SG&A to revenue (%): 4.101784028424178
Free cash flow (dilution-adjusted): 6104776.119402985
Buyback yield (%): 0
Retained earnings: 20955422.88557214
Inventory turnover: 2.6826975758830187
Receivables turnover: 5.041588639200999
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 26.183685272970582
FCF margin (%): 13.564939386368513
Revenue growth (%): 18.831721450822137
Rule of 40 score: 32.39666083719065
Financial ratios for VISTN.OL — quarterly report dated 2025-12-31
Total revenue: 11019303.482587064
Gross profit: 7230845.771144278
Operating income: 2071442.7860696516
Net income: 1598009.9502487562
Capital expenditures: 647661.6915422885
Operating cash flow: 4060995.024875622
Depreciation & amortization: 550447.7611940298
Net tangible assets: 32717810.94527363
Owner earnings: 1500796.0199004977
Return on net tangible assets (%): 4.587091790495539
Capex to operating income (%): 31.266211931981942
Buffett classification: The Good
Stock price: 1.9790836653386457
P/E ratio: 12.168139823852302
Shares outstanding: 44344592
Book value: 32717810.94527363
P/B ratio: 2.682381710075402
Market cap (USD): 87761657.67330678
Debt to equity: 0.0018825232502265718
Current ratio: 2.346909594095941
Quick ratio: 1.3998039667896678
Effective tax rate (%): 22.00097134531326
Interest coverage ratio: 12.289256198347108
COGS to revenue (%): 34.38019215487972
Free cash flow (dilution-adjusted): 3413333.333333333
Buyback yield (%): 0
Retained earnings: 20955422.88557214
Inventory turnover: 0.46356519304055616
Receivables turnover: 1.234439093989656
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.902265871305768
FCF margin (%): 30.97594452069638
Revenue growth (%): -5.698660601978644
Rule of 40 score: 25.277283918717735
Financial ratios for WLFC — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 90504000
Buffett classification: The Gruesome
Stock price: 12.42
Shares outstanding: 23899848
Market cap (USD): 296836112.16
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WLFC — annual report dated 2022-12-31
Total revenue: 311927000
Gross profit: 202834000
Operating income: 95889000
Net income: 5439000
Capital expenditures: 223785000
Operating cash flow: 144424000
Depreciation & amortization: 88260000
Net tangible assets: 385851000
Owner earnings: -130086000
Return on net tangible assets (%): -33.71405024219193
Capex to operating income (%): 233.3792197228045
Buffett classification: The Gruesome
Stock price: 19.47
P/E ratio: 85.5543372972973
Shares outstanding: 23899848
Book value: 404688000
P/B ratio: 1.1498488726129759
Market cap (USD): 465330040.56
Debt to equity: 4.564696754042621
Current ratio: 4.256949575554571
Quick ratio: 3.623532502503982
Effective tax rate (%): 44.46032880629021
Interest coverage ratio: 1.436689989961494
COGS to revenue (%): 34.97388812125914
SG&A to revenue (%): 29.66399189553966
Free cash flow (dilution-adjusted): -162150000
Buyback yield (%): 1.9126209838697117
Retained earnings: 357493000
Inventory turnover: 2.8279285584674807
Receivables turnover: 2.4294704539967134
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.8137241410579588
FCF margin (%): -51.98331660933487
Rule of 40 score: -51.98331660933487
Financial ratios for WLFC — annual report dated 2023-12-31
Total revenue: 418555000
Gross profit: 291264000
Operating income: 147415000
Net income: 43781000
Capital expenditures: 83719000
Operating cash flow: 229737000
Depreciation & amortization: 90925000
Net tangible assets: 428743000
Owner earnings: 50987000
Return on net tangible assets (%): 11.892205820269952
Capex to operating income (%): 56.79137129871451
Buffett classification: The Good
Stock price: 16.13
P/E ratio: 8.805293351910645
Shares outstanding: 23899848
Book value: 438963000
P/B ratio: 0.8782164971535186
Market cap (USD): 385504548.23999995
Debt to equity: 4.1071365923779455
Current ratio: 3.7409972012024464
Quick ratio: 3.316471441899036
Effective tax rate (%): 34.781766721287056
Interest coverage ratio: 1.8708674408274637
COGS to revenue (%): 30.41201275817993
SG&A to revenue (%): 27.652279867639855
Free cash flow (dilution-adjusted): 46155000
Buyback yield (%): 1.5027060060504154
Retained earnings: 397781000
Inventory turnover: 3.108145724471358
Receivables turnover: 2.7699429539528544
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.7676943386098065
FCF margin (%): 11.027224618031083
Revenue growth (%): 34.1836391206917
Rule of 40 score: 45.210863738722786
Financial ratios for WLFC — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 49.39
Shares outstanding: 23899848
Market cap (USD): 1180413492.72
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WLFC — annual report dated 2024-12-31
Total revenue: 569223000
Gross profit: 429441000
Operating income: 260390000
Net income: 108612000
Capital expenditures: 674957000
Operating cash flow: 284406000
Depreciation & amortization: 95209000
Net tangible assets: 515275000
Owner earnings: -471136000
Return on net tangible assets (%): -91.43389452234244
Capex to operating income (%): 259.2100311071854
Buffett classification: The Gruesome
Stock price: 68.92
P/E ratio: 15.16570474864656
Shares outstanding: 23899848
Book value: 549338000
P/B ratio: 2.9984773020617546
Market cap (USD): 1647177524.16
Debt to equity: 4.122329057884217
Current ratio: 3.853065130735596
Quick ratio: 3.2195813651289797
Effective tax rate (%): 28.84667037898392
Interest coverage ratio: 2.485491199266924
COGS to revenue (%): 24.556632462145767
SG&A to revenue (%): 25.781987024417496
Free cash flow (dilution-adjusted): -590951000
Buyback yield (%): 0.5004925018148324
Retained earnings: 491439000
Inventory turnover: 1.9373804573804574
Receivables turnover: 2.564991888968998
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.179871089830622
FCF margin (%): -103.81713317979069
Revenue growth (%): 35.99718077671991
Rule of 40 score: -67.81995240307077
Financial ratios for WLFC — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 68.92
Shares outstanding: 23899848
Market cap (USD): 1647177524.16
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WLFC — quarterly report dated 2025-03-31
Total revenue: 157732000
Gross profit: 112056000
Operating income: 58106000
Net income: 16869000
Capital expenditures: 10931000
Operating cash flow: 41013000
Depreciation & amortization: 25941000
Net tangible assets: 538720000
Owner earnings: 31879000
Return on net tangible assets (%): 5.9175452925452925
Capex to operating income (%): 18.812170860152136
Buffett classification: The Great
Stock price: 52.48
P/E ratio: 18.58829840298773
Shares outstanding: 23899848
Book value: 565488000
P/B ratio: 2.2180205822935233
Market cap (USD): 1254264023.04
Debt to equity: 3.946313626460685
Current ratio: 4.827741983262978
Quick ratio: 4.115540461907936
Effective tax rate (%): 33.202660964599666
Interest coverage ratio: 1.810494173365738
COGS to revenue (%): 28.957979357391018
SG&A to revenue (%): 30.2538482996475
Free cash flow (dilution-adjusted): -2699000
Buyback yield (%): 0
Retained earnings: 505083000
Inventory turnover: 0.678510948037672
Receivables turnover: 0.7144080040944439
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.8271683513033505
FCF margin (%): -1.711130271599929
Rule of 40 score: -1.711130271599929
Financial ratios for WLFC — quarterly report dated 2025-06-30
Total revenue: 195502000
Gross profit: 131229000
Operating income: 73292000
Net income: 60377000
Capital expenditures: 41043000
Operating cash flow: 104178000
Depreciation & amortization: 28130000
Net tangible assets: 582932000
Owner earnings: 47464000
Return on net tangible assets (%): 8.142287608160128
Capex to operating income (%): 55.999290509196086
Buffett classification: The Good
Stock price: 47.46
P/E ratio: 14.684084432591979
Shares outstanding: 23899848
Book value: 617937000
P/B ratio: 1.8356026359968733
Market cap (USD): 1134286786.08
Debt to equity: 4.532246814804745
Current ratio: 8.65074097755619
Quick ratio: 8.135909285893502
Effective tax rate (%): 18.735615166157448
Interest coverage ratio: 2.1833239000268105
COGS to revenue (%): 32.87587850763675
SG&A to revenue (%): 25.794621026894866
Free cash flow (dilution-adjusted): -47829000
Buyback yield (%): 1.6498473075467992
Retained earnings: 562121000
Inventory turnover: 1.0104387743872723
Receivables turnover: 0.9332283163874171
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.91718730217856
FCF margin (%): -24.464711358451577
Revenue growth (%): 23.945680014201304
Rule of 40 score: -0.5190313442502728
Financial ratios for WLFC — quarterly report dated 2025-09-30
Total revenue: 183389000
Gross profit: 142908000
Operating income: 85366000
Net income: 24324000
Capital expenditures: 109427000
Operating cash flow: 63882000
Depreciation & amortization: 28662000
Net tangible assets: 622889000
Owner earnings: -56441000
Return on net tangible assets (%): -9.061164990873174
Capex to operating income (%): 128.18569453880937
Buffett classification: The Gruesome
Stock price: 45.59
P/E ratio: 10.727518660234322
Shares outstanding: 23899848
Book value: 650204000
P/B ratio: 1.6757726349268847
Market cap (USD): 1089594070.3200002
Debt to equity: 3.44422827297279
Current ratio: 3.7503253553052307
Quick ratio: 3.2873986227343637
Effective tax rate (%): 43.716593007381356
Interest coverage ratio: 2.497761652573368
COGS to revenue (%): 22.073843033115402
SG&A to revenue (%): 26.82276472416557
Free cash flow (dilution-adjusted): -109140000
Buyback yield (%): 0.0018355459656756619
Retained earnings: 583094000
Inventory turnover: 0.753667709264224
Receivables turnover: 0.9800033131870187
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.5826848837631453
FCF margin (%): -59.5128388289374
Revenue growth (%): -6.195844543789834
Rule of 40 score: -65.70868337272724
Financial ratios for WLFC — annual report dated 2025-12-31
Total revenue: 730241000
Gross profit: 498499000
Operating income: 272380000
Net income: 113758000
Capital expenditures: 285999000
Operating cash flow: 283235000
Depreciation & amortization: 113050000
Net tangible assets: 631234000
Owner earnings: -59191000
Return on net tangible assets (%): -9.377029754417537
Capex to operating income (%): 105
Buffett classification: The Gruesome
Stock price: 45.16
P/E ratio: 9.487835015383533
Shares outstanding: 23899848
Book value: 662137000
P/B ratio: 1.6300510856212536
Market cap (USD): 1079317135.6799998
Debt to equity: 4.078216441612536
Current ratio: 5.6693015539927405
Quick ratio: 5.2682055353902
Effective tax rate (%): 29.169961458716
Interest coverage ratio: 2.062547326972588
COGS to revenue (%): 31.735002553951368
SG&A to revenue (%): 26.667223560441006
Free cash flow (dilution-adjusted): -316992000
Buyback yield (%): 2.1381111479769888
Retained earnings: 590785000
Inventory turnover: 4.096046096470297
Receivables turnover: 4.1570800742334715
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.176848800042368
FCF margin (%): -43.40923065125075
Revenue growth (%): 28.287332029802027
Rule of 40 score: -15.121898621448725
Financial ratios for WLFC — quarterly report dated 2025-12-31
Total revenue: 193618000
Gross profit: 112306000
Operating income: 55616000
Net income: 12188000
Capital expenditures: 146460000
Operating cash flow: 74162000
Depreciation & amortization: 30317000
Net tangible assets: 631234000
Owner earnings: -103955000
Return on net tangible assets (%): -16.468536232205487
Capex to operating income (%): 263.3414844649022
Buffett classification: The Gruesome
Stock price: 45.16
P/E ratio: 9.487835015383533
Shares outstanding: 23899848
Book value: 662137000
P/B ratio: 1.6300510856212536
Market cap (USD): 1079317135.6799998
Debt to equity: 4.078216441612536
Current ratio: 5.6693015539927405
Quick ratio: 5.2682055353902
Effective tax rate (%): 31.677784629183247
Interest coverage ratio: 1.7261328367473618
COGS to revenue (%): 41.9960954043529
SG&A to revenue (%): 24.479129006600626
Free cash flow (dilution-adjusted): -157324000
Buyback yield (%): 0.40238404973194364
Retained earnings: 590785000
Inventory turnover: 1.4371917917174823
Receivables turnover: 1.1022190342817457
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.465407235711713
FCF margin (%): -81.25484200849094
Revenue growth (%): 5.577760934407189
Rule of 40 score: -75.67708107408374
Financial ratios for XPEV — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 50.33
Shares outstanding: 782239490
Market cap (USD): 39370113531.7
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for XPEV — annual report dated 2022-12-31
Total revenue: 3858494109.195402
Gross profit: 443734339.0804598
Operating income: -1250793534.4827585
Net income: -1313070689.6551723
Capital expenditures: 603272844.8275862
Operating cash flow: -1182812643.678161
Depreciation & amortization: 202687356.3218391
Net tangible assets: 4758597557.471265
Owner earnings: -1713656178.1609194
Return on net tangible assets (%): -36.01179039547866
Buffett classification: The Gruesome
Stock price: 9.94
Shares outstanding: 782239490
Book value: 5303256465.517242
P/B ratio: 1.466167171276269
Market cap (USD): 7775460530.599999
Debt to equity: 0.3475580025447929
Current ratio: 1.8050046168641376
Quick ratio: 1.6175113321238161
Interest coverage ratio: -65.85514251997095
COGS to revenue (%): 88.49980519542662
R&D to revenue (%): 19.41840585401986
SG&A to revenue (%): 24.90492036173811
Free cash flow (dilution-adjusted): -1957293247.1264367
Buyback yield (%): 0
Retained earnings: -3639499425.2873564
Inventory turnover: 5.2565289349053925
Receivables turnover: 4.061316610855002
Capitalized R&D asset: 749258045.9770114
ROCI (R&D-adjusted, %): -9.942702668448895
FCF margin (%): -50.72686886995362
Rule of 40 score: -50.72686886995362
Financial ratios for XPEV — annual report dated 2023-12-31
Total revenue: 4314496061.884669
Gross profit: 63453586.49789029
Operating income: -1535692405.063291
Net income: -1459321378.3403656
Capital expenditures: 293663291.1392405
Operating cash flow: 134481575.2461322
Depreciation & amortization: 296383122.3628692
Net tangible assets: 4016323769.338959
Owner earnings: -1456601547.116737
Return on net tangible assets (%): -36.26703499943375
Buffett classification: The Gruesome
Stock price: 14.59
Shares outstanding: 782239490
Book value: 5109497468.35443
P/B ratio: 2.233658834315
Market cap (USD): 11412874159.1
Debt to equity: 0.4236543914923938
Current ratio: 1.5098108744229894
Quick ratio: 1.3567792221228203
Interest coverage ratio: -40.64069513820133
COGS to revenue (%): 98.52929321089303
R&D to revenue (%): 17.20094691408778
SG&A to revenue (%): 21.38130028207332
Free cash flow (dilution-adjusted): -268055696.20253164
Buyback yield (%): 0
Retained earnings: -5029578199.718706
Inventory turnover: 5.469372510500864
Receivables turnover: 4.963406686184136
Capitalized R&D asset: 1244137068.0197875
ROCI (R&D-adjusted, %): -16.128850143931427
Rosenberg metric: -0.5075431016382267
FCF margin (%): -6.212908584402296
Revenue growth (%): 11.818132664827512
Rule of 40 score: 5.6052240804252165
Financial ratios for XPEV — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 12.18
Shares outstanding: 782239490
Market cap (USD): 9527676988.199999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for XPEV — quarterly report dated 2024-12-31
Total revenue: 2206177534.2465754
Gross profit: 318462602.739726
Operating income: -241184931.50684932
Net income: -182188082.19178084
Capital expenditures: 0
Net tangible assets: 3272025890.410959
Owner earnings: -182188082.19178084
Return on net tangible assets (%): -5.568051363092926
Buffett classification: The Gruesome
Stock price: 11.82
Shares outstanding: 782239490
Book value: 4284217534.2465744
P/B ratio: 2.1581702371296654
Market cap (USD): 9246070771.800001
Debt to equity: 0.509625996505556
Current ratio: 1.2476160785421093
Quick ratio: 1.1080716579551984
Interest coverage ratio: -18.730119892341573
COGS to revenue (%): 85.56496030821549
R&D to revenue (%): 12.458559700606566
SG&A to revenue (%): 14.128447293949693
Buyback yield (%): 0
Retained earnings: -5696650547.945206
Inventory turnover: 2.477172787970063
Receivables turnover: 2.1956746897954837
Capitalized R&D asset: 274857945.20547944
ROCI (R&D-adjusted, %): -0.9432103351599979
Rule of 40 score: 0
Financial ratios for XPEV — annual report dated 2024-12-31
Total revenue: 5598124520.547945
Gross profit: 800790136.9863014
Operating income: -944162054.7945206
Net income: -793186849.3150685
Capital expenditures: 281722191.7808219
Operating cash flow: -275663424.65753424
Depreciation & amortization: 352416438.3561644
Net tangible assets: 3272025890.410959
Owner earnings: -722492602.7397261
Return on net tangible assets (%): -22.080895046004134
Buffett classification: The Gruesome
Stock price: 11.82
Shares outstanding: 782239490
Book value: 4284217534.2465744
P/B ratio: 2.1581702371296654
Market cap (USD): 9246070771.800001
Debt to equity: 0.509625996505556
Current ratio: 1.2476160785421093
Quick ratio: 1.1080716579551984
Interest coverage ratio: -20.037045543080744
COGS to revenue (%): 85.69538540904196
R&D to revenue (%): 15.79965051407016
SG&A to revenue (%): 16.812489721056043
Free cash flow (dilution-adjusted): -673141780.8219178
Buyback yield (%): 0
Retained earnings: -5696650547.945206
Inventory turnover: 6.295349997717027
Receivables turnover: 5.5714737954161455
Capitalized R&D asset: 1628969163.4956322
ROCI (R&D-adjusted, %): -11.358746104781508
Rosenberg metric: 0.9935353647978032
FCF margin (%): -12.024416004880695
Revenue growth (%): 29.75152695127407
Rule of 40 score: 17.727110946393374
Financial ratios for XPEV — quarterly report dated 2025-03-31
Total revenue: 2177772451.7906337
Gross profit: 338778236.91460055
Operating income: -127165013.77410468
Net income: -91466391.18457301
Capital expenditures: 0
Net tangible assets: 3165691322.3140497
Owner earnings: -91466391.18457301
Return on net tangible assets (%): -2.8893022683498124
Buffett classification: The Gruesome
Stock price: 20.72
Shares outstanding: 782239490
Book value: 4229347245.179064
P/B ratio: 3.832270393800161
Market cap (USD): 16208002232.8
Debt to equity: 0.5764868208534092
Current ratio: 1.211622467039146
Quick ratio: 1.072574004125223
Interest coverage ratio: -7.1603366037150495
COGS to revenue (%): 84.4438184239108
R&D to revenue (%): 12.527800919735762
SG&A to revenue (%): 12.308581291015132
Buyback yield (%): 0
Retained earnings: -5821046280.991735
Inventory turnover: 2.236757474343905
Receivables turnover: 3.4228332226350915
Capitalized R&D asset: 456981820.53285027
ROCI (R&D-adjusted, %): -0.543616548764664
Rosenberg metric: 0.07391321418664794
Revenue growth (%): -1.2875247805314185
Rule of 40 score: -1.2875247805314185